Filing Details
- Accession Number:
- 0001209191-21-037942
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-03 19:39:37
- Reporting Period:
- 2021-06-02
- Accepted Time:
- 2021-06-03 19:39:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 462702363 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757799 | Calvin Yu | C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-02 | 1,844 | $17.77 | 126,686 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
- The shares were acquired pursuant to the Issuer's 2019 Employee Stock Purchase Plan on May 28, 2021.